Role of Calcium Channels in Vascular Function
NCT02885558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2021-06-01
Summary
The purpose of this study is to examine the role of T-type calcium channels in endothelial dysfunction observed with ageing.
Conditions
- Endothelium, Vascular
Interventions
- DRUG
-
Efonidipine
8 weeks treatment with either efonidipine
- DRUG
-
Nifedipine
8 weeks treatment with either nifedipine
Sponsors & Collaborators
-
University of Southern Denmark
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2021-05-25
- Completion
- 2021-05-25
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
NCT01594489 ·Status: COMPLETED ·Phase: PHASE4
-
Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease
NCT00835887 ·Status: WITHDRAWN ·Phase: PHASE2
-
Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
NCT00317252 ·Status: COMPLETED ·Phase: PHASE2
-
N-Acetyl Cystein and Contrast Nephropathy
NCT01820195 ·Status: UNKNOWN ·Phase: PHASE3
-
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
NCT01144091 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Citrate Dialysate on Vascular Calcification
NCT04956120 ·Status: COMPLETED ·Phase: NA
-
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
NCT06139952 ·Status: COMPLETED ·Phase: PHASE4
-
Endovenous Versus Liposomal Iron in CKD
NCT01864161 ·Status: COMPLETED ·Phase: PHASE4
-
Arginase Inhibition in Ischemia-reperfusion Injury
NCT02009527 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Apixaban in Nephrotic Syndrome
NCT02599532 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Amlodipine in Reduction of CIN
NCT07291375 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
NCT00173706 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
NCT00556465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Folic Acid for Prevention of Contrast Induced Nephropathy
NCT02444013 ·Status: UNKNOWN ·Phase: PHASE4
-
Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.
NCT06429345 ·Status: RECRUITING ·Phase: PHASE4
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
NCT01722513 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
NCT00161369 ·Status: COMPLETED
-
PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography
NCT00259441 ·Status: COMPLETED ·Phase: PHASE4
-
Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.
NCT07266220 ·Status: NOT_YET_RECRUITING
-
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial
NCT03759158 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast Renal Injury With Different Hydration Strategies
NCT01218828 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01093131 ·Status: WITHDRAWN ·Phase: PHASE4